Identifiers
HUGO:1L2
Maps_Modules
MODULE:INPUT_ACTIVATORS MODULE:IMMUNE_STIMULATION MODULE:IMMUNOSTIMULATORY_CYTOKINE_PATHWAYS MODULE:EFFECTOR_ACTIVATION MODULE:IMMUNOSTIMULATORY_CYTOKINE_EXPRESSION
References
NATURAL_KILLER
CASCADE:Fc_gamma_RIII
CASCADE:IL15
CASCADE:CD40LG
CASCADE:NKp30
PMID:6164929
IL2 has the ability to augment the cytotoxic activity of natural killer (NK) cells agains tumor cells
and potentiate effect of other cytokines (interferons).
PMID:15289500
Dendric cells-derived IL-2 induces NK cell activation.
DC-derived IL-2 Is Required In Vitro to Elicit IFNγ Production from NK Cells.
PMID:23650441
IL-2–treated NK cells had a significantly increased contact efficiency as determined by the number of target cell contacts that cells underwent before initiating Ca2+ flux for the first time
The ability of IL-2 to modulate NK cell cytotoxicity directly correlated with its ability to increase target–cell conjugation.
IL-2 rapidly increases NK cell adhesion to and killing of weak targets.
NK cell reactivity toward missing-self targets was enhanced in the absence of T reg cells and depended on the availability of IL-2 and activated T cells.
CD4+ T cell–derived IL-2 activated NK cells in the absence of T reg cells.
PMID:19528259
Nkp30 signaling induces IL2 release.
PMID:9625766
IL2 stimulates NKp44 surface expression in NK cells.
PMID:10807786
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4
PMID:15563472
Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells.
15353479
Human and mouse DCs produce IL-2 downstream of IL15+CD40L signaling